Our study’s KEGG results align with these findings, identifying key pathways linked to metabolic and cardiovascular health, including the AGE-RAGE signaling pathway, insulin resistance, and non-alcoholic fatty liver disease. The gene discussed is RENBP; the disease is metabolic dysfunction-associated steatotic liver disease.